KINDERHOOK, N.Y.--(BUSINESS WIRE)--American Bio Medica Corporation (NASDAQ: ABMC) announced today that they have launched the patent pending OralStat® EX, a new oral fluid point of collection test that dramatically improves the limits of detection over other point of collection oral fluid drug tests on the market. The OralStat EX is simple to perform and the results are ready to read within minutes. The OralStat EX was developed for use in those markets where speed and accuracy are vital.
